🇺🇸 FDA
Pipeline program

Galinpepimut-S + Montanide + GM-CSF

10-134

Phase 2 mab completed

Quick answer

Galinpepimut-S + Montanide + GM-CSF for Malignant Pleural Mesothelioma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Malignant Pleural Mesothelioma
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials